609 related articles for article (PubMed ID: 21576002)
21. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
Terris B; Cavard C; Perret C
J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
[TBL] [Abstract][Full Text] [Related]
22. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
[TBL] [Abstract][Full Text] [Related]
23. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
24. Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
Richter CE; Cocco E; Bellone S; Bellone M; Casagrande F; Todeschini P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2010 Dec; 20(9):1440-7. PubMed ID: 21370592
[TBL] [Abstract][Full Text] [Related]
25. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
Chan AW; Tong JH; Chan SL; Lai PB; To KF
Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
[TBL] [Abstract][Full Text] [Related]
26. Expression of epithelial cell adhesion molecule in paired tumor samples of patients with primary and recurrent serous ovarian cancer.
Pietzner K; Woopen H; Richter R; Joens T; Braicu EI; Dimitrova D; Mellstedt H; Darb-Esfahani S; Denkert C; Lindhofer H; Fotopoulou C; Sehouli J
Int J Gynecol Cancer; 2013 Jun; 23(5):797-802. PubMed ID: 23694980
[TBL] [Abstract][Full Text] [Related]
27. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.
Seligson DB; Pantuck AJ; Liu X; Huang Y; Horvath S; Bui MH; Han KR; Correa AJ; Eeva M; Tze S; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Apr; 10(8):2659-69. PubMed ID: 15102668
[TBL] [Abstract][Full Text] [Related]
28. Revisiting the Roles of Pro-Metastatic EpCAM in Cancer.
Mohtar MA; Syafruddin SE; Nasir SN; Low TY
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32046162
[TBL] [Abstract][Full Text] [Related]
29. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.
Münz M; Kieu C; Mack B; Schmitt B; Zeidler R; Gires O
Oncogene; 2004 Jul; 23(34):5748-58. PubMed ID: 15195135
[TBL] [Abstract][Full Text] [Related]
30. Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab.
Seeber A; Braicu I; Untergasser G; Nassir M; Fong D; Botta L; Gastl G; Fiegl H; Zeimet A; Sehouli J; Spizzo G
Oncotarget; 2015 Sep; 6(28):25017-23. PubMed ID: 26296970
[TBL] [Abstract][Full Text] [Related]
31. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors.
Went P; Dirnhofer S; Salvisberg T; Amin MB; Lim SD; Diener PA; Moch H
Am J Surg Pathol; 2005 Jan; 29(1):83-8. PubMed ID: 15613858
[TBL] [Abstract][Full Text] [Related]
32. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
[TBL] [Abstract][Full Text] [Related]
33. Spatial and temporal expression patterns of the epithelial cell adhesion molecule (EpCAM/EGP-2) in developing and adult kidneys.
Trzpis M; Popa ER; McLaughlin PM; van Goor H; Timmer A; Bosman GW; de Leij LM; Harmsen MC
Nephron Exp Nephrol; 2007; 107(4):e119-31. PubMed ID: 18025791
[TBL] [Abstract][Full Text] [Related]
34. Cysteine-poor region-specific EpCAM monoclonal antibody recognizing native tumor cells with high sensitivity.
Takao M; Nagai Y; Torii T
Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):73-80. PubMed ID: 23607341
[TBL] [Abstract][Full Text] [Related]
35. Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM.
Munz M; Fellinger K; Hofmann T; Schmitt B; Gires O
Front Biosci; 2008 May; 13():5195-201. PubMed ID: 18508581
[TBL] [Abstract][Full Text] [Related]
36. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.
Liao MY; Lai JK; Kuo MY; Lu RM; Lin CW; Cheng PC; Liang KH; Wu HC
Oncotarget; 2015 Sep; 6(28):24947-68. PubMed ID: 26317650
[TBL] [Abstract][Full Text] [Related]
37. Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy.
Simon M; Stefan N; Plückthun A; Zangemeister-Wittke U
Expert Opin Drug Deliv; 2013 Apr; 10(4):451-68. PubMed ID: 23316711
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
Sterzynska K; Kempisty B; Zawierucha P; Zabel M
Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
[TBL] [Abstract][Full Text] [Related]
39. The overexpression of epithelial cell adhesion molecule (EpCAM) in glioma.
Chen X; Ma WY; Xu SC; Liang Y; Fu YB; Pang B; Xin T; Fan HT; Zhang R; Luo JG; Kang WQ; Wang M; Pang Q
J Neurooncol; 2014 Aug; 119(1):39-47. PubMed ID: 24906438
[TBL] [Abstract][Full Text] [Related]
40. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
Bae JS; Noh SJ; Jang KY; Park HS; Chung MJ; Park CK; Moon WS
Int J Oncol; 2012 Dec; 41(6):2150-8. PubMed ID: 22993038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
